Journal of Cutaneous Immunology and Allergy (Oct 2020)

Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits

Mariko Ogawa‐Momohara,
Yoshinao Muro,
Takuya Takeichi,
Masashi Akiyama

Affiliations

Mariko Ogawa‐Momohara: Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
Yoshinao Muro: Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
Takuya Takeichi: Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
Masashi Akiyama: Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan

DOI: https://doi.org/10.1002/cia2.12132
Journal volume & issue: Vol. 3, no. 5
pp. 120 – 121

Abstract

No abstracts available.

Published in Journal of Cutaneous Immunology and Allergy

ISSN: 2574-4593 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Dermatology; Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.frontierspartnerships.org/journals/journal-of-cutaneous-immunology-and-allergy

About the journal